Nuzenio

Biomedicines

Biomedicines news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 19 latest news signals 17 publisher sources 100/100 entity strength

Latest news

Generate Biomedicines, Inc. (GENB) Stock Price, News, Quote & History - Yahoo! Finance CanadaYahoo! Finance Canada · Fri, 07 Aug 2026 12:03:39 GMTGenerate Biomedicines, Inc. (GENB) stock price, news, quote and history - Yahoo Finance UKYahoo Finance UK · Fri, 07 Aug 2026 01:30:58 GMTPress Release: Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update - MoomooMoomoo · Thu, 06 Aug 2026 11:00:00 GMTGenerate Biomedicines reports Q2 2026: $6.3M revenue, $67.3M net loss, $457.4M cash - TradingViewTradingView · Thu, 06 Aug 2026 10:13:01 GMTGenerate Biomedicines, Inc. Q2 2026: Revenue $6.3M, EPS $(0.52) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 10:11:01 GMTGenerate Biomedicines (GENB) posts Q2 loss but holds $457.4M cash after IPO - Stock TitanStock Titan · Thu, 06 Aug 2026 10:06:48 GMTGoodwin Guides Sail Biomedicines In Strategic Collaboration To Advance In Vivo CAR-T Medicines - MondaqMondaq · Mon, 03 Aug 2026 06:29:34 GMTJohnson & Johnson Secures $2.58 Billion Option To Acquire Sail Biomedicines - Pulse 2.0Pulse 2.0 · Sun, 02 Aug 2026 13:15:20 GMT

Timeline

Fri, 07 Aug 2026 12:03:39 GMTGenerate Biomedicines, Inc. (GENB) Stock Price, News, Quote & History - Yahoo! Finance Canada
Fri, 07 Aug 2026 01:30:58 GMTGenerate Biomedicines, Inc. (GENB) stock price, news, quote and history - Yahoo Finance UK
Thu, 06 Aug 2026 11:00:00 GMTPress Release: Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update - Moomoo
Thu, 06 Aug 2026 10:13:01 GMTGenerate Biomedicines reports Q2 2026: $6.3M revenue, $67.3M net loss, $457.4M cash - TradingView
Thu, 06 Aug 2026 10:11:01 GMTGenerate Biomedicines, Inc. Q2 2026: Revenue $6.3M, EPS $(0.52) — 10-Q Summary - TradingView
Thu, 06 Aug 2026 10:06:48 GMTGenerate Biomedicines (GENB) posts Q2 loss but holds $457.4M cash after IPO - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Biomedicines.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

17 distinct publisher/source names are currently connected to this entity page.